Form 4: 10x Genomics CFO Sells Shares
Insider Transaction (Form 4)
Adam Taich, Chief Financial Officer of 10x Genomics, Inc., sold 17,166 shares of common stock on August 24, 2026 for $63.02 per share.
Summary
- Open-market sale: disposed of 17,166 Class A Common Stock at $63.02 ($1,081,853) on August 24, 2026; holds 362,732 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,081,853 of stock on the open market.
Insider Transactions
Adam Taich — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Class A Common Stock | 17,166 | $63 | $1.1M | 362,732 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (17,166 shares) |
Keywords
insider transaction, Form 4, TXG, 10x Genomics, Inc., bearish, Adam Taich
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.